GleamWall
中文EN

IRMD IRADIMED CORP

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1325618 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY11.0%
TTM net income YoY13.2%
TTM EPS YoY13.3%
Revenue 3-yr CAGR12.4%
Net income 3-yr CAGR13.7%

Margins

Gross margin75.5%
Operating margin32.3%
Net margin26.8%
FCF margin29.3%
EBITDA margin33.9%

Returns

ROE23.4%
ROA20.3%
ROIC (approx.)52.3%
Asset turnover0.76x

Leverage & solvency

Liabilities / assets12.1%
Debt / equity0.00x
Current ratio8.99x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.13x
Accruals ratio-2.7%
Payout ratio67.7%
Capex / revenue1.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$24.20M$20.47M$21.98M$22.69M$21.20M$20.41M$19.51M$19.39M
Cost of revenue$5.75M$5.31M$5.17M$5.66M$4.71M$4.45M$4.67M$4.63M
Gross profit$18.46M$15.16M$16.81M$17.03M$16.49M$15.96M$14.84M$14.76M
R&D expense$875,000$657,000$956,000$799,031$674,000$877,000$624,000$569,993
SG&A expense$4.53M$3.87M$4.57M$4.54M$4.36M$4.28M$4.61M$3.87M
Operating income$8.14M$6.39M$7.24M$7.09M$6.83M$6.79M$5.43M$5.80M
Pretax income$8.67M$6.89M$7.77M$7.79M$7.30M$7.33M$5.95M$6.34M
Income tax$2.16M$1.67M$1.95M$1.35M$1.72M$1.55M$1.26M$1.20M
Net income$6.51M$5.22M$5.82M$6.44M$5.58M$5.77M$4.69M$5.15M
EBITDA$8.44M$6.69M$7.69M$7.47M$7.09M$6.92M$5.63M$6.00M
EPS (basic)0.510.410.46—0.440.450.37—
EPS (diluted)0.510.410.45—0.430.450.37—
Weighted avg. shares (diluted)12.88M12.87M12.87M—12.86M12.84M12.83M—
Balance sheet
Cash & equivalents$63.29M$59.08M$56.37M$51.16M$56.53M$53.00M$50.33M$52.23M
Receivables$13.67M$13.19M$13.41M$13.67M$13.86M$10.92M$12.71M$10.56M
Inventory$13.49M$12.26M$11.88M$11.62M$11.73M$11.20M$10.56M$10.40M
Current assets$92.80M$86.72M$86.42M$81.20M$84.92M$77.37M$75.14M$75.24M
PP&E, net$24.08M$24.21M$24.23M$23.86M$23.79M$22.94M$20.38M$16.81M
Intangibles$3.41M$3.44M$3.29M$3.38M$3.37M$3.37M$3.26M$3.10M
Total assets$121.07M$114.97M$114.39M$108.78M$114.72M$106.45M$101.73M$98.33M
Current liabilities$10.32M$9.16M$12.12M$10.18M$12.80M$8.81M$8.47M$8.51M
Total liabilities$14.62M$13.23M$15.88M$14.16M$16.37M$12.15M$11.68M$11.51M
Shareholders' equity$106.45M$101.75M$98.51M$94.62M$98.35M$94.30M$90.06M$86.82M
Shares outstanding12.79M12.79M12.78M12.78M12.72M12.72M12.72M12.71M
Cash flow statement
Operating cash flow$7.00M$5.94M$8.29M$5.92M$6.99M$7.75M$4.29M$5.99M
Capital expenditure$130,000$185,000$403,000$294,174$1.14M$2.64M$3.70M$2.79M
Free cash flow$6.87M$5.75M$7.89M$5.63M$5.85M$5.11M$595,000$3.20M
Investing cash flow-$212,000-$443,000-$469,000-$416,407-$1.26M-$2.82M-$3.92M-$3.06M
Financing cash flow-$2.58M-$2.79M-$2.61M-$10.87M-$2.19M-$2.26M-$2.28M-$2.42M
Depreciation & amortization$305,000$303,000$455,000$381,000$256,000$136,000$194,000$195,210
Stock-based compensation$777,000$807,000$684,000$696,236$666,000$731,000$826,000$656,835
Dividends paid$2.56M$2.56M$2.56M$8.55M$2.16M$2.16M$2.16M$1.90M

Free plan shows the latest 8 periods; Pro shows all 54 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.